Recent News
June 23, 2026
AI Tool Developed at NewYork-Presbyterian and Columbia to Detect Hidden Heart Disease Receives FDA Approval
Developed by Dr. Pierre Elias, EchoNext is the world’s first FDA-approved AI detection tool that analyzes electrocardiograms (ECGs) to detect high-risk structural heart disease.
June 22, 2026
Doctors Thought It Was Asthma. A.I. Flagged a Serious Heart Problem.
EchoNext, an artificial intelligence tool developed by Dr. Pierre Elias, has received the world’s first FDA clearance for AI detection of hidden heart disease through electrocardiograms (ECGs).
June 11, 2026
Columbia Cancer Researchers Receive 2026 Lotus Awards for Innovative Ovarian Cancer Research
Dr. Acharyya's project will examine how ovarian tumors may activate stress-response pathways in the brain that subsequently promote cancer spread. Dr. Danino's project seeks to develop engineered probiotic bacteria that can selectively colonize ovarian tumors and deliver therapeutic molecules directly within the tumor microenvironment.